Early markers of cognitive enhancement: developing an implicit measure of cognitive performance.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 23820927)

Published in Psychopharmacology (Berl) on July 03, 2013

Authors

Abbie Pringle1, Michael Browning, Elizabeth Parsons, Phil J Cowen, Catherine J Harmer

Author Affiliations

1: Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK, Abbie.pringle@psych.ox.ac.uk.

Articles cited by this

An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61

Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71

Attentional bias in emotional disorders. J Abnorm Psychol (1986) 6.56

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci (2009) 3.79

Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology (2007) 2.88

Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci (2000) 2.47

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44

Implicit cognition and addiction: a tool for explaining paradoxical behavior. Annu Rev Clin Psychol (2010) 2.26

Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17

Switching attention and resolving interference: fMRI measures of executive functions. Neuropsychologia (2003) 1.58

Implicit social cognition: from measures to mechanisms. Trends Cogn Sci (2011) 1.41

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2004) 1.38

Cognitive enhancement by drugs in health and disease. Trends Cogn Sci (2010) 1.35

Implicit learning as an ability. Cognition (2010) 1.27

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology (2004) 1.23

Efficacy markers in depression. J Psychopharmacol (2010) 1.19

Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev (2010) 1.16

Impact of modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry (2006) 1.06

Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav (2005) 1.04

Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology (Berl) (2006) 0.97

Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology (2010) 0.92

Modafinil improves rapid shifts of attention. Psychopharmacology (Berl) (2008) 0.92

Effects of modafinil on cognitive and meta-cognitive performance. Hum Psychopharmacol (2004) 0.91

Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol (2003) 0.91

Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology (2012) 0.90

The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav (2004) 0.90

Neural networks of response shifting: influence of task speed and stimulus material. Brain Res (2006) 0.89

Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol (2005) 0.89

Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res (2009) 0.88

Implicit cognitive processes in psychopathology: an introduction. J Behav Ther Exp Psychiatry (2006) 0.77

Articles by these authors

Increased neural processing of rewarding and aversive food stimuli in recovered anorexia nervosa. Biol Psychiatry (2011) 2.06

Neural processing of reward and punishment in young people at increased familial risk of depression. Biol Psychiatry (2012) 1.87

Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol Psychiatry (2005) 1.73

Lateral prefrontal cortex mediates the cognitive modification of attentional bias. Biol Psychiatry (2009) 1.70

Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry (2009) 1.63

Changes in automatic threat processing precede and predict clinical changes with exposure-based cognitive-behavior therapy for panic disorder. Biol Psychiatry (2013) 1.58

Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry (2009) 1.49

Increased waking salivary cortisol levels in young people at familial risk of depression. Am J Psychiatry (2007) 1.47

Using attentional bias modification as a cognitive vaccine against depression. Biol Psychiatry (2012) 1.44

Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl) (2009) 1.43

The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders. Cogn Affect Behav Neurosci (2010) 1.40

Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol (2008) 1.34

Cognitive Bias Modification Using Mental Imagery for Depression: Developing a Novel Computerized Intervention to Change Negative Thinking Styles. Eur J Pers (2011) 1.30

Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry (2004) 1.20

Risk for depression and neural responses to fearful facial expressions of emotion. Br J Psychiatry (2009) 1.17

Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci (2007) 1.11

Highly neurotic never-depressed students have negative biases in information processing. Psychol Med (2007) 1.11

Enhanced early morning salivary cortisol in neuroticism. Am J Psychiatry (2005) 1.10

Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br J Psychiatry (2007) 1.10

Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology (Berl) (2009) 1.09

Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. Int J Neuropsychopharmacol (2008) 1.04

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology (Berl) (2009) 0.98

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Exp Brain Res (2007) 0.97

Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology (Berl) (2006) 0.97

The role of the anterior cingulate cortex in the counting Stroop task. Exp Brain Res (2003) 0.96

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers. Int J Neuropsychopharmacol (2010) 0.96

Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neurosci Biobehav Rev (2007) 0.96

Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br J Psychiatry (2008) 0.95

The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers. J Cogn Neurosci (2009) 0.95

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berl) (2009) 0.94

Frontolimbic responses to emotional faces in young people at familial risk of depression. J Affect Disord (2010) 0.94

Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) (2014) 0.93

A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology (Berl) (2002) 0.91

Emotional bias and waking salivary cortisol in relatives of patients with major depression. Psychol Med (2006) 0.91

Internet-based attention bias modification for social anxiety: a randomised controlled comparison of training towards negative and training towards positive cues. PLoS One (2013) 0.91

A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology (Berl) (2010) 0.90

The common adolescent bipolar phenotype shows positive biases in emotional processing. Bipolar Disord (2010) 0.89

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology (2007) 0.89

Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers. J Psychopharmacol (2007) 0.88

Single dose antidepressant administration modulates the neural processing of self-referent personality trait words. Neuroimage (2007) 0.87

Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety. Neuropsychopharmacology (2011) 0.87

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action. Biol Psychiatry (2007) 0.87

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. J Psychopharmacol (2011) 0.87

Idiopathic chronic cough and organ-specific autoimmune diseases: a case-control study. Respir Med (2004) 0.86

Risk for depression is associated with neural biases in emotional categorisation. Neuropsychologia (2008) 0.86

Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity. Psychopharmacology (Berl) (2014) 0.85

Blockade of sensitisation-induced facilitation of appetitive conditioning by post-session intra-amygdala nafadotride. Behav Brain Res (2002) 0.85

A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression. Biol Psychiatry (2009) 0.85

NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers. Int J Neuropsychopharmacol (2009) 0.84

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials (2010) 0.84

Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. Neuropsychopharmacology (2012) 0.84

Short-term NK1 receptor antagonism and emotional processing in healthy volunteers. Psychopharmacology (Berl) (2010) 0.83

Impaired emotional categorisation in young people at increased familial risk of depression. Neuropsychologia (2007) 0.83

Lack of effect of tyrosine depletion on mood in recovered depressed women. Neuropsychopharmacology (2005) 0.82

Exogenous NGF restores endogenous NGF distribution in the brain of the cognitively impaired aged rat. Brain Res (2003) 0.81

Neural responses to emotional faces in women recovered from anorexia nervosa. Psychiatry Res (2012) 0.81

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology (Berl) (2010) 0.81

The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology (Berl) (2011) 0.81

Social inference and social anxiety: evidence of a fear-congruent self-referential learning bias. J Behav Ther Exp Psychiatry (2012) 0.80

Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial. Trials (2013) 0.80

Altered NGF response but not release in the aged septo-hippocampal cholinergic system. Exp Neurol (2005) 0.80

Expectancy and surprise predict neural and behavioral measures of attention to threatening stimuli. Neuroimage (2011) 0.79

Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactin. Psychopharmacology (Berl) (2001) 0.79

Bilateral generic working memory circuit requires left-lateralized addition for verbal processing. Cereb Cortex (2007) 0.79

Combined NK₁ antagonism and serotonin reuptake inhibition: effects on emotional processing in humans. J Psychopharmacol (2013) 0.79

Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity. Psychopharmacology (Berl) (2009) 0.79

Corpus callosum volume in railroad workers with chronic exposure to solvents. J Occup Environ Med (2006) 0.79

Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study. Exp Clin Psychopharmacol (2012) 0.78

Preclinical development of hybrid cell vaccines for multiple myeloma. Eur J Haematol (2007) 0.78

Isolation rearing-induced facilitation of Pavlovian learning: abolition by postsession intra-amygdala nafadotride. Physiol Behav (2002) 0.77

Effects of seven-day diazepam administration on resting-state functional connectivity in healthy volunteers: a randomized, double-blind study. Psychopharmacology (Berl) (2014) 0.76

A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology (2016) 0.76

Effects of pramipexole on the processing of rewarding and aversive taste stimuli. Psychopharmacology (Berl) (2013) 0.76

Cognitive vulnerability and implicit emotional processing: imbalance in frontolimbic brain areas? Cogn Affect Behav Neurosci (2015) 0.76

Effects of alpha-lactalbumin on emotional processing in healthy women. J Psychopharmacol (2007) 0.76

Have no fear: the neural basis of anxiolytic drug action in generalized social phobia. Biol Psychiatry (2013) 0.75

Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study. Psychopharmacology (Berl) (2013) 0.75

Correction: Affective bias as a rational response to the statistics of rewards and punishments. Elife (2017) 0.75

Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males. J Neurosci (2013) 0.75

Accidental cannulation of an aberrant radial artery. Paediatr Anaesth (2008) 0.75